Disclosure 0001104659-26-095040-1

SEC FORM 4

$0.00

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Acquisition (code M) of 10,001 shares at $0 per share.

Reporting Person Kirby Daniel Gordon · Officer Title Chief Commercial Officer · Transaction Code M

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095040 · filed 2026-08-12 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "IOVANCE BIOTHERAPEUTICS, INC. (IOVA)." Disclosed 2026-08-12. https://desqlong.com/cards/0001104659-26-095040-1 (retrieved 2026-09-26).